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The specific reaction of O6-alkylguanine-DNA alkyl-
transferase (AGT) with O6-benzylguanine (BG) derivatives
allows for a specific labeling of AGT fusion proteins with
chemically diverse compounds in living cells and in vitro.
The efficiency of the labeling depends on a number of fac-
tors, most importantly on the reactivity, selectivity and sta-
bility of AGT. Here, we report the use of directed evolution
and two different selection systems to further increase the
activity of AGT towards BG derivatives by a factor of 17
and demonstrate the advantages of this mutant for the spe-
cific labeling of AGT fusion proteins displayed on the sur-
face of mammalian cells. The results furthermore identify
two regions of the protein outside the active site that influ-
ence the activity of the protein towards BG derivatives.
Keywords: directed evolution/O6-alkylguanine-DNA
alkyltransferases/phage display/protein labeling
Introduction
The specific labeling of proteins in living cells with synthetic
probes is an important approach to study protein function. One
way to achieve such a labeling is through expression of the
protein of interest as a fusion protein with an additional
polypeptide (a so-called tag) that mediates the labeling
(Johnsson and Johnsson, 2003). Factors that affect the
feasibility and attractiveness of such an approach are (i) the
size of the tag, (ii) the specificity and speed of the labeling,
(iii) the availability of a broad range of different probes and (iv)
properties of the tag that affect the function of the fusion protein
such as tag-dependent localization or stability. We have
previously used human O6-alkylguanine-DNA alkyltransferase
(AGT) as a tag for the specific labeling of AGT fusion proteins
in living cells as well as in vitro (Keppler et al., 2003). The
labeling is achieved through the reaction of O6-benzylguanine
(BG) derivatives with AGT, leading to an irreversible transfer
of the derivatized benzyl group to the active site cysteine of
AGT. In earlier experiments we optimized the properties of
AGT with respect to a number of important parameters (Table I)
(Juillerat et al., 2003; Juillerat et al., 2005). Firstly, we used
saturation mutagenesis of active site residues to increase the
activity of AGT versus BG derivatives 20-fold relative to
wild-type human AGT (Juillerat et al., 2003). Importantly, such
an increased activity directly translates into a more efficient
labeling of AGT fusion proteins in living cells and in vitro.
Secondly, we truncated the size of AGT to 182 residues,
removed non-essential cysteines to facilitate folding under
oxidizing conditions and introduced mutations to prevent the
binding of AGT fusion proteins to DNA (Juillerat et al., 2005).
Thirdly, we introduced mutations into AGT to render it
resistant against an inhibitor of wild-type AGT (Juillerat et al.,
2005). The latter point is important in case endogenous AGT
interferes with the specific labeling of AGT fusion proteins. We
then assembled all 15 different mutations in a single protein
which was named MAGT (Table I). Although MAGT conserved
beneficial properties of its predecessors such as lack of affinity
for DNA and resistance against an inhibitor of wild-type AGT,
its activity decreased by a factor of8 relative to its most active
predecessor (Juillerat et al., 2005). The observed decrease in
activity diminishes the practical value of the mutant for
applications in living cells as well as in vitro.
Here, we describe our efforts to restore the decreased activity
of this AGT mutant. Using directed evolution, we were able to
generate an AGT mutant with a 17-fold increased activity,
generating the most active AGT mutant characterized so far.
Materials and methods
Phage selections
The error-prone library insert was prepared by a modified
PCR as described elsewhere (Zaccolo and Gherardi, 1999).
Saturation mutagenesis of residues 31–35 and 150–154 was
performed by overlap extension PCR using the synthetic
oligonucleotides with the corresponding codons randomized
as NNK. The PCR products were ligated into the phagemid
pAK100 and electroporated into Escherichia coli JM109
(Krebber et al., 1997). The colonies were scraped off the
plates, resuspended in 2YT medium containing 20% glycerol
and stocked at 80C prior to further use.
Phages were prepared as described previously (Juillerat
et al., 2003). For the phage selections, BGDG or BGFL were
added to 500 ml of phage preparation to a final concentration
of either 5 or 50 nM and incubated for 10 min. Phages were
subjected to two cycles of precipitation with 4% w/v
polyethylene glycol 8000 and 3% w/v NaCl. After resuspen-
sion of the phages in 500 ml of phosphate-buffered saline
(PBS), 500 ml of PBSMM (PBS + 4% w/v skimmed milk
powder) was added and the solution rotated for 60 min at
room temperature. The sample was added to 25 ml of anti-
digoxigenin antibody-coated magnetic beads (Roche) or to
100 ml of anti-fluorescein antibody-coated magnetic beads
(Polyscience) and rotated for 30 min. The beads were washed
twice with PBS and blocked for 60 min with PBSMM before
addition of the phage. After addition of the phages the beads
were washed three times with PBSM (PBS + 2% w/v
skimmed milk powder), five times with PBST [PBS/0.05%
(v/v) Tween-20] and twice with PBS. Phages were eluted by
incubating the beads with 100 ml of 0.1 M glycine (pH 2.5)
for 5 min. The supernatant was neutralized with 50 ml of 1 M
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Tris–HCl (pH 8.0). E.coli JM109 (OD600 = 0.5–0.6) were
infected with the eluted phage, plated on 2YT plates
containing 25 mg/ml Cam and incubated overnight at 37C.
The colonies were scraped off the dishes, aliquoted and stored
at 80C prior to the next round of selection. After the
selections, the mutants were characterized as described below.
Yeast three-hybrid selections
The error-prone PCR library was generated by two sequential
PCR reactions. First, the gene of MAGT was amplified using
Taq polymerase under standard conditions used for error-
prone PCR and the resulting PCR product reamplified using
the GENEMORPH kit (Stratagene). The final PCR product
was ligated into the pHybLex/Zeo plasmid (Invitrogen) and
electroporated into E.coli XL1-Blue, yielding a library of at
least 3.2 · 105 independent clones. To check the success of
this strategy, the sequences of 10 randomly picked clones
were determined by DNA sequencing. Colonies were scraped
off the plates and the plasmid DNA was isolated for further
transformation into L40 yeast cells.
The large-scale transformation of the yeast strain L40
containing the plasmid for expression of B42–DHFR
(dihydrofolate reductase) was performed using standard
procedures (Gietz and Woods, 2002). For the selections, the
transformed yeast were grown on a plate lacking uracil,
tryptophane and histidine but containing zeocin (200 mg/ml)
and BGMtx (0.25 mM) at 30C for 5 days. The plasmid DNA
(pHybLex/Zeo–AGT) of 24 of the fastest growing colonies
was isolated by standard phenol:chloroform precipitation
using acid-washed glass beads, electroporated in XL1-Blue
and analyzed by DNA sequencing. The genes of the selected
AGT mutants were subcloned into the pGEX-2T plasmid
(Amersham Biosciences) as described elsewhere (Juillerat
et al., 2003), allowing for the expression of the AGT mutants
as GST fusion proteins. Activity assays and competition
assays were performed by a fluorescence assay as described
elsewhere (Juillerat et al., 2005). The observed rate constants
were obtained by measuring the rate of labeling under pseudo
first-order conditions and dividing the resulting pseudo first-
order rate constant by the concentration of BGCy3. If not
specified otherwise, given values are average values of at least
three measurements.
Expression and labeling of GPI-anchored AGT mutants on
mammalian cells
The gene of AGT with a C-terminal HA epitope tag was
inserted downstream of the endoplasmic reticulum signal
sequence of huCD59 (amino acids 1–25: MGIQGGSVLF-
GLLLVLAVFCHSGHSRS) and upstream of the glycosylpho-
sphatidylinositol (GPI) signal sequence of huCD59 (amino
acids 100–128: EFLENGGTSLSEKTVLLLVTPFLAAAWS-
LHP Stop), which contains the GPI attachment site at the
underlined asparagine 102 (Chen et al., 2001; Hiscox et al.,
2002). The propeptide 103–128 is removed in the mature
form and the numbering corresponds to the huCD59
sequence. This construct was inserted into the mammalian
expression vector pEGFP-F (Clontech) using the NheI and
SalI restriction sites. Labeling experiments were carried out in
HEK293T cells. Cells were cultured in DMEM/F12 medium
(Cambrex) supplemented with 5% FCS in humidified atmo-
sphere under 5% CO2. Twenty-four hours before transfection,
cells were seeded in a 12-well cell culture plate to a density of
100 000 cells per well. One hour before transfection, the
medium was exchanged for DMEM/F12, 3% FCS. Transfec-
tion was performed with calcium phosphate as described
elsewhere (Keppler et al., 2004a). An aliquot of 2.5 mg DNA
per well (1.5 mg AGT containing plasmid and 1.0 mg pEGFP-
N1) were used for transfection. For in vivo labeling, the
medium was aspirated 24 h after transfection and the cells
were incubated for 5 min with 2.5 mM BGCy3 in Dulbecco’s
PBS (DPBS). Afterwards, the cells were washed three times
for each 10 min with DPBS.
Imaging was carried out with a Zeiss Axiovert200
microscope, equipped with LD Plan Neofluar ·40 (0.6 corr.
phase 2) and ·63 (0.75 corr. phase 2) objectives and an
AxioCam MR digital camera (Zeiss). Zeiss filter sets 10
(excitation 450–490 nm; emission 515–565 nm) and 43
(excitation 545 6 25 nm; emission 605 6 70 nm) were used
for fluorescence microscopy. Image analysis was performed
with the AxioVision 4.0 (Zeiss) software.
For western blot analysis, HEK293T cells were grown in
suspension culture in ExCell-293 medium (JRH Biosciences).
Transfection and protein expression was carried out in a 12-
well cell culture plate. For transfection, 7.5 mg linear PEI
(polyethylenimine in water, pH 7.1) and 2.5 mg DNA where
mixed and diluted to a final volume of 100 ml (in 150 mM
NaCl) and incubated for 10 min at room temperature. This
transfection cocktail was added to 1 ml of cell suspension [2 ·
106 cells/ml in RPMI-1640 medium (Cambrex) containing
25 mM HEPES pH 7.3]. After 4 h of incubation (humidified
atmosphere, 5% CO2) the transfection mixture was diluted
with 1 ml of Pro293s-CD medium (Cambrex) and incubation
was continued for 24 h (humidified atmosphere, 5% CO2).
Suspension cultures were agitated (150–200 r.p.m.) during all
incubations. The cells were harvested by centrifugation,
washed once with 500 ml of PBS and resuspended in lysis
buffer (150 mM KH2PO4 pH 7.0; 100 mM NaCl; 0.5 mM
EDTA; 0.1% TX100) and subjected to three freeze-thaw
cycles (liquid nitrogen/37C water bath). Cell debris and the
nuclei were separated by centrifugation and the resulting
Table I. Engineering of AGT for labeling applications
Mutations Phenotype Reference
N157G, S159E 23-Fold increase in activity relative to wild-type Juillerat et al. (2003)
C62A, C150N Removal of non-essential cysteines Juillerat et al. (2005)
G131K, G132T, M134L, R135S Resistance against N9-substituted BG derivatives used for inhibition of wild-type Juillerat et al. (2005)
Q115S, Q116H, K125A, A127T,
R128A, S151I, S152N,
Suppress affinity towards DNA Keppler et al. (2004b);
Juillerat et al. (2005)
Delete residues 183–207 Reduce size of protein Keppler et al. (2004b)
Combination of mutations
listed above (MAGT)
8-Fold decrease in activity versus BG relative to most active mutant
described previously
Juillerat et al. (2005)
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extract was directly subjected to western blot analysis using a
mouse anti-HA antibody as primary antibody and a goat
anti-mouse IgG antibody–peroxidase conjugate as secondary
antibody.
Results
Random mutagenesis of AGT
As a strategy to isolate AGT mutants with increased activity
against BG derivatives we focused on random mutagenesis of
MAGT. To select AGT mutants out of libraries generated
through random mutagenesis we used phage display (Juillerat
et al., 2003). Here, phages displaying AGT on the tip of the
phage as a pIII fusion protein were incubated first with BG-
digoxigenin (BGDG, Fig. 1) and subsequently with beads
covered with anti-digoxigenin antibodies, thereby allowing
for an enrichment of phages displaying reactive AGT. For the
selections using phage display, the gene of MAGT was
subjected to error-prone PCR and subsequently cloned into
phagemid pAK100, yielding a library of 4 · 107 independent
clones. MAGT contained in average 2–3 base mutations per
gene as determined by the sequencing of five randomly
picked clones. Two selections were run in parallel: in one
selection, phages were incubated with 5 nM BGDG for 10
min before recovering labeled phage; in the other the BGDG
concentration was increased to 50 nM. Both selections were
repeated for six rounds after which individual clones were
assayed in cell extracts for activity. A total of 49 clones from
both selections were analyzed and the sequences of 21 clones
with significantly higher activity determined through DNA
sequencing (Table II). A clone with the single mutation
A154T, which lead to an 4-fold increase in activity, was
found seven times and 15 clones in total contained the
mutation A154T alone or in combination with other
mutations. The most active mutant possessed a 6-fold higher
activity than MAGT and contained, in addition to the mutation
A154T, the mutations L33F, V44A and V52A.
To complement the phage selections with another selection
system which might be better suited for proteins used in
intracellular applications we focused on a previously
established AGT-based yeast three-hybrid system in which
the reaction of AGT with BG-methotrexate (BGMtx, Fig. 1)
leads to transcription of the reporter genes HIS3 and lacZ
(Gendreizig et al., 2003). As the growth of yeast on plates
lacking histidine and containing BGMtx critically depends on
the activity of AGT, we envisioned isolating AGT mutants
out of libraries generated through error-prone PCR in a simple
growth assay. For the yeast three-hybrid selections, the gene
of MAGT was also subjected to random mutagenesis using
error-prone PCR and subsequently cloned into the plasmid
pHybLex/Zeo, yielding a library of 3 · 105 independent
clones after transformation of E.coli. In this construct, MAGT
is expressed as a LexA-MAGT fusion protein and MAGT
contained in average three base mutations per gene as
Fig. 1. (A) General scheme for labeling of AGT fusion proteins. (B) AGT-based three-hybrid system. AGT is expressed as fusion with the DNA-binding domain
LexA and DHFR as fusion protein with the transcriptional activation domain B42. Labeling of the AGT fusion protein in yeast with methotrexate using BGMtx
(C) induces dimerization of the AGT and DHFR fusion proteins and transcription of reporter genes (here HIS3 and lacZ) under LexA. (C) BG derivatives
used in this work.
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determined by the sequencing of 10 randomly picked clones.
Plasmid DNA of the library was transformed into the
Saccharomyces cerevisiae yeast strain L40, which also
contained a plasmid encoding a B42–DHFR fusion protein.
The transformed yeast cells were plated on selective plates
containing 0.25 mM BGMtx and after 5 days of incubation at
30C the plasmids from 24 of the faster growing colonies
were isolated. The MAGT-based genes were subcloned into
the vector pGEX-2T, allowing for the expression of a GST–
AGT fusion protein in E.coli, the DNA sequence was
determined and the activities of purified proteins measured
(Table III). The mutation L33F was found in two different
clones which displayed activities 2-fold higher than MAGT.
The mutation L33F was also one of the mutations found in the
most active clone isolated from the phage selections. Another
mutation that was found in both selections was the mutation
V164M, which appears to increase the activity of AGT versus
BG by a factor of 2. Furthermore, a clone with 1.9-fold
higher activity and the mutations D42E, P47L, V155L and
K178M was found three times and MAGT was recovered
twice. The clone with the mutation A154T, which was the
most active mutant in the phage display selections, was not
isolated in the yeast three-hybrid experiments.
Saturation mutagenesis of residues 150–154 and 31–35
The selections based on random mutagenesis point to two
regions of the protein outside the active site that affect the
activity against BG derivatives: the loop around Thr154 and
the residues around Leu33. Point mutations accessible
through error-prone PCR are generally limited to those
arising from one or two base-per-codon mutations (Kuchner
and Arnold, 1997). Based on the results from the previous
selections and this reasoning we decided to create two new
libraries through saturation mutagenesis of residues 31–35
and 150–154. The corresponding regions of the gene were
randomized using standard procedures, yielding libraries of
1.2 · 107 and 3.8 · 106 independent clones, respectively. The
library with randomized residues 31–35 was subjected to four
rounds of phage panning at a substrate concentration of 50
nM BGDG. Twenty-two clones were screened for activity in
cell extracts and the four most active clones were analyzed
through DNA sequencing (Table IV). Except at residue 31,
where hydrophobic side chains were conserved, no obvious
consensus at any of the other positions was found, indicating
that these residues are neither critical for folding nor activity
of the protein. The two most active clones C1 and C2
displayed a 4.3- and 3.5-fold increase in activity, respectively.
However, expression of clone C1 in E.coli yielded signifi-
cantly lower amounts of soluble protein compared to C2 or
MAGT. Concerning the library with the randomized residues
150–154, four rounds of selections were performed at a
concentration of 5 nM BGFL. Forty-four clones were
screened for activity in cell extracts. Of these 44, 7 clones
displayed significantly higher activity than MAGT and were
analyzed through DNA sequencing and their activity
Table II. AGT mutants selected using phage displaya
Clone Mutations krel
A1 A154T 4.2
A2 K104E, T127A, A154T 4.5
A3 A154T 4.4
A4 A154T 4.1
A5 K107R, A154T 4.7
A6 K8T, T127A, A154T, H174R 5.8
A7 T127A 2.2
A8 N123S 1.3
A9 A154T 4.1
A10 A154T 3.0
A11 L33F, V44A, V52A, A154T 6.1
A12 V46A, A50V, P58V, A154T 3.4
A13 V149I, A154T 4.5
A14 A154T 4.2
A15 H71Y, A154T 3.3
A16 K8T, A51T, I112V, A154T 5.5
A17 N150D 1.8
A18 A154T 4.2
A19 M1V, V164M 1.9
A20 K8R, K104E, I151T 1.4
A21 V52A, I151S, K178E 2.3
aActivities of mutants were measured as GST–AGT-His6 fusion proteins in
E.coli cell extracts.
Table III. AGT mutants selected using yeast three-hybrid systema
Clone Mutations krel
B1 K36M, Q97L, R175L nd
B2 E92D, I151V, R175W 1.0
B3 L66M, K131R 1.5
B4 R175L 0.6
B5 D42E, P47L, V155L, K178M 1.9
B6 E110D, L120M 0.7
B7 T11I, N67K, Q72L 1.0
B8 G37W, L66V, V81M nd
B9 M60K, A68V, K104M, A121T, E166K nd
B10 V52I, V164M 2.1
B11 Q90R, K101N, F108I, V164L 1.2
B12 L33F, A68T 2.1
B13 D42E, P47L, V155L, K178M 1.9
B14 A41D, S115T, I151N 1.6
B15 T38M, A41D, A64T, G173C 0.8
B16 G122C 0.9
B17 D42E, A51T, A64V, K104M 0.5
B18 D42E, P47L, V155L, K178M 1.9
B19 F79I, V88I, F89L 0.7
B20 V44G, V106A, I151T, A170T 1.4
B21 E25K 0.7
B22 L33F, N123Y 2.2
B23 No mutations nd
B24 No mutations nd
aActivities of mutants were measured as GST–AGT fusion proteins after
purification; nd: not determined; standard deviation of all values below 20%.
Table IV. AGT mutants selected after saturation mutagenesis of residues
31–35 and 150–154a
Clone Position krel Clone Position krel
31 32 33 34 35 150 151 152 153 154
MAGT I K L L G 1 MAGT N I N G A 1
C1 L G S S R 4.3 D1 Q G D L D 7.3
C2b I I F L G 3.5 D2 E G E G R 6.8
C3 A Y M T F 2.1 D3 E G R E R 4.1
C4 L S P M G 1.9 D4 V S R D D 7.8
D5 V N D L D 5.8
D6 E G W N E 4.4
D7 E S H G K 5.7
aActivities of mutants C1–C4 were measured as GST–AGT-His6 fusion proteins
in E.coli cell extracts and of mutants D1–D7 as GST–AGT-His6 fusion proteins
after purification.
bC2 also possesses the point mutation G182V. Standard deviation of all values
below 13%.
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measured after purification of the protein as GST fusion
(Table IV). Clone D4 showed an 8-fold increased reactivity
relative to MAGT and thus was the fastest mutant isolated up
to this point in these selections. We then combined the
mutations of clone C2 resulting from saturation mutagenesis
of residues 31–35 (Table IV) and D4 in a single clone and
measured the activity of the purified mutant. The resulting
mutant, abbreviated in the following as NAGT, possesses a
17-fold higher activity than MAGT and a 52-fold higher
activity than wild-type AGT, and is the most active AGT
mutant against BG derivatives described so far (Table V).
Characterization of the selected mutant NAGT and its
application for protein labeling
One of the advantages of AGT fusion proteins for covalent
labeling is that a single fusion protein can be derivatized with
a large variety of different labels. This is possible as
previously used AGT mutants did not discriminate between
BG derivatives carrying different probes attached to the
benzyl group. To verify that the mutations K32I and L33F or
any of the other mutations in NAGT did not result in
discrimination between different substrates, we performed a
competition assay between BGCy3 and BGFL. In these
experiments, the reaction of NAGT with BGCy3 (1 mM) was
almost completely quenched through the addition of BGFL
(1 mM) (Fig. 2). Furthermore, NAGT can be efficiently
biotinylated using BGBT (data not shown). These experi-
ments demonstrate that NAGT can react with BG derivatives
with different probes and linkers.
Another important property is the affinity of the engineered
AGT towards (alkylated) DNA. The activity of wild-type
AGT towards alkylated guanine incorporated in DNA
compared to the corresponding alkylated nucleobase is at
least four orders of higher magnitude (Pegg, 2000).
Consequently, the reaction of wild-type AGT with BGCy3
is efficiently quenched in the presence of oligonucleotides
containing BG (Fig. 2) (Juillerat et al., 2005). In contrast, the
reaction of NAGT is not significantly quenched in the
presence of oligonucleotides containing BG (Fig. 2), indicat-
ing that NAGT does not possess significant affinity towards
DNA.
To investigate the use of NAGT for applications as a tag in
protein labeling we compared the efficiency of labeling of
different AGT mutants expressed as cell surface proteins. To
allow for a labeling of an AGT fusion displayed on the cell
surface of a mammalian cell it must fold and remain active
under the oxidizing conditions of the secretory pathway and
the cell surface. We have previously expressed AGT as an
N-terminal fusion with the G protein-coupled NK1 receptor,
leading to the display of AGT (carrying the mutations N157G,
S159E, K125A, A127T and R128A; abbreviated as KAGT) on
the extracellular side of the plasma membrane (Keppler et al.,
2004b). While this protein could be specifically labeled with
fluorescent BG derivatives, the signal proved to be relatively
weak compared to the fluorescence signal observed with
NK1 constructs with EGFP (data not shown) or a labeling
strategy based on expression of NK1 as fusion with acyl
carrier protein and subsequent chemical labeling (George
et al., 2004). We decided to compare the efficiency of the
labeling of this mutant KAGT on the surfaces of living cells
with that of NAGT. Compared to KAGT, NAGT has an
3-fold higher activity towards BG derivatives and two non-
essential cysteines have been removed through site-directed
Table V. Kinetic properties of AGT mutantsa
Mutant kobs (M
1 s1) krel
wt AGT (human) 100 1
wt AGT (mouse) 20 0.2
MAGT 300 3
NAGT 5200 52
aActivities of mutants were measured as GST–AGT-His6 fusion proteins after
purification. Standard deviation of all values below 20%.
Fig. 2. Reaction of NAGT with BGCy3 in the presence of competing substrates. The assay is based on a 3-fold increase in the intensity of fluorescence upon
reaction of NAGT with BGCy3 and the quenching of this fluorescence increase upon reaction of AGT with a competing substrate. (A) Reaction of NAGT or wild-
type-like AGT containing the mutations N157G, S159E with BGCy3 (1 mM) in the presence of varying concentrations of an oligonucleotide (22mer) containing
BG. Reactions were analyzed by measuring differences in relative fluorescence intensity at t1 and t0 (DRFI) and plotting these values as a function of
concentration of oligonucleotide containing BG. Values measured in the absence of oligonucleotide were arbitrarily set to 1. (B) Reaction of NAGT with BGCy3
(1 mM) in presence or absence of BGFL (1 mM). Reactions were analyzed by following the increase in fluorescence intensity (FI) as a function of time.
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mutagenesis. To investigate if NAGT allows for a more
efficient labeling of AGT fusion proteins on cell surfaces, we
transiently expressed both NAGT and KAGT with a
C-terminal signal sequence that leads to display of the
proteins on the cell surface via a GPI anchor. HEK293T cells
were co-transfected with mixtures of plasmids leading to
co-expression of EGFP and either KAGT–GPI or NAGT–GPI.
The expression of the GPI fusions was verified by western
blotting and both proteins were expressed to about the same
level (Fig. 3D). When cells expressing KAGT–GPI were
incubated with BGCy3, no significant labeling of cell surface
proteins was observed, indicating that most of the protein is
not active or properly translocated (Fig. 3A). However,
when these experiments were repeated with cells expressing
NAGT–GPI, a strong fluorescence labeling of cell surface
proteins upon addition of BGCy3 was observed (Fig. 3B).
Similar results were also observed when these experiments
were repeated with CHO cells as expression host (Fig. 3C).
These experiments clearly demonstrate the value of NAGT
over previously described AGT mutants for labeling
applications on the cell surfaces of live cells.
Discussion
The value of AGT as a tag in protein labeling depends on a
number of key properties. These include (i) the speed and
selectivity of the labeling, (ii) its size, (iii) expression yields in
different hosts, (iv) absence of AGT-dependent localization,
Fig. 3. Cell surface labeling of AGT mutants expressed as GPI fusion proteins. (A) Labeling of HEK293T cells transiently expressing KAGT–GPI and EGFP.
Images from left to right: phase contrast; EGFP (green), Cy3 (red). (B) Labeling of HEK293 cells transiently expressing NAGT–GPI and EGFP. Images from left
to right: phase contrast; EGFP (green), Cy3 (red). (C) Labeling of CHO cells transiently expressing NAGT–GPI. Image shown is overlay of phase contrast and
fluorescence (Cy3, red). (D) Western blot of HEK293T cell extracts transiently expressing KAGT–GPI (lane 1) or NAGT–GPI (lane 2) probed with an anti-HA
antibody.
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(v) absence of activity against any other cellular substrates
and (vi) the availability of a wide range of different substrates
for protein labeling in living cells and in vitro. Using a
combination of rational design and directed evolution we have
previously generated AGT mutants that were optimized with
respect to activity, substrate specificity, size, absence of DNA
binding and expression properties (Juillerat et al., 2003,
2005). However, when the corresponding mutations were
assembled in a single protein, the activity of this AGT mutant,
MAGT, dropped by a factor of 8 while retaining the other
beneficial properties of its predecessors (Juillerat et al., 2005).
To restore the activity of MAGT we decided to use directed
evolution based on random mutagenesis. Previous directed
evolution experiments were based on saturation mutagenesis
of mainly active site residues. Random mutagenesis might
allow the identification of other regions of the protein, more
distant from the active site, that affect activity. Furthermore,
the earlier directed evolution experiments were exclusively
based on phage display of AGT and the labeling and
subsequent isolation of phage displaying active AGT. Phage
selections in general are biased towards proteins that can be
secreted to and folded in the periplasm of E.coli, properties
not necessarily important for AGT fusion proteins. To
complement the selections based on phage display we
established a yeast three-hybrid system in which the
alkylation of an AGT fusion protein leads to formation of a
functional transcription factor (Fig. 1A). When error-prone
libraries based on MAGT were subjected to selections using
either phage display or the yeast three-hybrid system, a
number of mutants with significantly increased activity were
isolated. These two independent selections pointed towards
two regions of AGT that significantly affect its activity
towards BG derivatives. Firstly, mutations of Thr154 or
amino acids located in the loop around Thr154 (i.e. N150,
I151) appear to affect the activity of MAGT (Fig. 4). The
mutations C150N, S151I and S152N were incorporated into
MAGT to remove the non-essential cysteine C150 and to
suppress the interaction of AGT with DNA as S151 and S152
contribute to the protein–DNA interaction (Daniels et al.,
2004). The present study results of the performed directed
evolution experiments thus suggest that at least one of the
mutations is responsible for the decreased activity of MAGT
towards BG derivatives. It should also be noted that the region
150–154 and in particular residues 150, 152 and 154 have
been previously identified as hot spots for resistance against
BG (Encell et al., 1998; Davis et al., 2001), indicating that
this loop not only plays a role in the interaction of AGT with
DNA but that its conformation also modulates the activity of
the protein versus BG. Secondly, mutations at position L33
also appear to affect the activity of MAGT versus BG
derivatives. When BG is docked into the active site of AGT,
Cd1 of L33 is within 4.5 s of the C-4 of the benzyl ring of
Fig. 4. Structure of wild-type AGT with BG docked into the active site. Highlighted are residues 31–35 and 150–154.
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BG. Steric repulsion between the linker attached to the C-4 of
BG and L33 might be attenuated through mutations at this
position or favorable interactions introduced.
It is instructive to compare the efficiency of phage display
and the yeast three-hybrid system for the selection of AGT
mutants with increased activity. The selections based on
phage display required six rounds of panning to identify the
best mutant out of a library of randomly mutated AGT;
analysis of clones after four rounds did not identify any
mutants with significantly increased activity (data not shown).
In contrast, after a single round of growth selection with the
yeast three-hybrid system 40% of the analyzed mutants
possessed an increased activity. Mutants isolated after six
rounds of phage selections possessed in average slightly
higher activity than those isolated after one round of growth
selections using the yeast three-hybrid system, but these
differences should be interpreted with caution, as only 24
mutants have been analyzed after the selections based on the
yeast three-hybrid system. The higher activity of the mutants
isolated from the phage selections might also be due to the
100-fold larger size of the library used in phage display
compared to that used in the yeast three-hybrid system. In
general, the transformation efficiency of E.coli is larger than
that of yeast. Another potential advantage of phage display is
the possibility to perform the selections in vitro. This yields
access to a much larger range of reaction conditions, such as
variations in pH and temperature, and should also allow
covering a larger dynamic range of the selections with respect
to rate enhancements. Nevertheless, the here established yeast
three-hybrid system is a valuable alternative to phage display
for the directed evolution of AGT and another example of a
growing list of yeast three-hybrid systems successfully used
for the directed evolution of enzymatic activity (Firestine
et al., 2000; Baker et al., 2002; Lin et al., 2004; Carter et al.,
2005).
Based on the results from these two selections, we decided
to subject the regions of residues 31–35 and 150–154 to
saturation mutagenesis. Libraries based on error-prone PCR
often allow the identification of so-called hot spots of activity
but not necessarily the best mutation at these hot spots
(Kuchner and Arnold, 1997). We decided to subject the
resulting libraries to selections using phage display and not
the yeast three-hybrid system mainly for two practical
reasons. Firstly, transformation of libraries into an expression
host is generally more efficient with E.coli than with yeast.
Secondly, isolation of plasmids for subcloning is also easier
from E.coli than from yeast. These selections then yielded
mutants with activities increased up to 8-fold (saturation
mutagenesis of residues 150–154) and up to 4-fold (saturation
mutagenesis of residues 31–35). When recombining mutants
from both selections, a mutant with a 17-fold increased
activity relative to the starting mutant MAGT was identified,
indicating that the effects of the different mutations on the
activity are at least partially additive. In addition to its
increased activity the mutant, which is referred to as NAGT,
reacts with structurally diverse BG derivatives, displays no
significant affinity towards DNA and retains its activity even
under a variety of different conditions, including the oxidizing
conditions of the secretory pathway and the cell surface.
Previously used AGT mutants often showed diminished
activities under such conditions. One important application
we foresee for this mutant should be in labeling experiments
in living animals such as mice. Here, the 260-fold higher
activity of NAGT compared to mouse wild-type AGT
(Table V), as well as the possibility to express NAGT
functionally on cell surfaces makes the protein an attractive
candidate for in vivo applications.
In summary, we report here the generation of an AGT
mutant with optimized conditions for the labeling of AGT
fusion proteins in living cells and in vitro using directed
evolution. The high activity of the mutant towards BG
derivatives, its lack of affinity towards DNA and its stability
under oxidizing conditions should make this protein a
valuable tool for a variety of applications.
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